{"id":"b3fa733e-8f42-4ddb-b08f-20514f1b4cd5","modelId":"cd51c658-641a-4d09-b0ac-57aaf6874f42","versionId":null,"locationId":"63e09f85-2dc7-4e87-a172-6f58dcb3673a","operatorId":"02ead9de-6bce-472d-9e76-d9c954d8d603","ownerId":null,"slug":"liberty-endovascular-boston-massachusetts-usa","status":"pilot","firstSeen":"2024-07-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["surgical_assistance"],"shiftStructure":null,"hoursPerDay":8,"siteType":"hospital","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"verified_coordinates","deploymentScale":"small_2_10","siteEnvironment":"indoor","operatorType":null,"sourceQualityTier":2,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://evtoday.com/news/microbots-liberty-system-pivotal-trial-commences-enrollment","name":"Endovascular Today","title":"Microbot's Liberty System Pivotal Trial Commences Enrollment"}],"notes":"First procedure in a patient using the LIBERTY endovascular robotic surgical system performed by Dmitry Rabkin, MD at Brigham and Women's Hospital as part of the pivotal clinical trial. LIBERTY investigational units shipped to BWH.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"healthcare","scaleTier":"pilot_lt10","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-08T22:32:41.253Z","updatedAt":"2026-08-21T14:23:17.339Z","model":{"id":"cd51c658-641a-4d09-b0ac-57aaf6874f42","companyId":"02ead9de-6bce-472d-9e76-d9c954d8d603","modelName":"LIBERTY Endovascular Robotic System","slug":"liberty-endovascular","description":"Microbot Medical is a Hingham, MA-based commercial-stage medical device company (Nasdaq: MBOT) that developed the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The LIBERTY system received FDA 510(k) clearance in 2025.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://ir.microbotmedical.com/news-events/press-release","title":"Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System","sourceName":"GlobeNewswire"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"FDA cleared","value":"LIBERTY Endovascular Robotic System; Nasdaq=MBOT"},{"label":"Stock","value":"Nasdaq: MBOT"},{"label":"Product","value":"LIBERTY Endovascular Robotic System"},{"label":"FDA clearance","value":"510(k) (2025)"},{"label":"Key feature","value":"Single-use, remotely operated"},{"label":"Ticker","value":"MBOT (Nasdaq)"},{"label":"Category","value":"Endovascular surgical robotics"}],"createdAt":"2026-07-02T21:26:26.322Z","updatedAt":"2026-07-12T04:24:54.291Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"02ead9de-6bce-472d-9e76-d9c954d8d603","name":"Microbot Medical","slug":"microbot-medical","description":"Microbot Medical Inc. (Nasdaq: MBOT) is a commercial-stage medical device company developing the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The company received FDA 510(k) clearance in September 2025 and commenced limited market release in November 2025, expanding to a full market release in Q2 2026. Headquartered in Hingham, Massachusetts with R&D operations in Yokneam, Israel.","status":"public","founded":2011,"hq":"Hingham, MA, USA","hqLat":42.2417669,"hqLng":-70.8897676,"hqGeocodedAt":"2026-08-05T00:51:16.415Z","hqAddress":null,"hqPrecision":null,"website":"microbotmedical.com","fundingTotal":"92200000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://ir.microbotmedical.com/news-events/press-release","title":"Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System","sourceName":"GlobeNewswire"}],"keyFacts":[{"label":"FDA cleared","value":"LIBERTY Endovascular Robotic System; Nasdaq=MBOT"},{"label":"Stock","value":"Nasdaq: MBOT"},{"label":"Product","value":"LIBERTY Endovascular Robotic System"},{"label":"FDA clearance","value":"510(k) (2025)"},{"label":"Key feature","value":"Single-use, remotely operated"},{"label":"Ticker","value":"MBOT (Nasdaq)"},{"label":"Category","value":"Endovascular surgical robotics"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"MBOT","stockExchange":"NASDAQ","secCik":"0000883975","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-02T21:26:26.164Z","updatedAt":"2026-08-21T22:25:39.297Z"}},"version":null,"location":{"id":"63e09f85-2dc7-4e87-a172-6f58dcb3673a","name":"Boston, Massachusetts, USA","slug":"boston-massachusetts-usa","kind":"city","parentLocationId":null,"region":"North America","lat":42.3588336,"lng":-71.0578303,"reviewStatus":"reviewed","aliases":["Boston, MA","Boston, Massachusetts, USA","Greater Boston"],"collisionRisk":"moderate","reviewNote":"Verified — Boston, Massachusetts, USA. 5 deployments: QinetiQ Talon (ended 2013), Waymo Driver Gen6 pilot (2025), Liberty Endovascular pilot (2024), EndoQuest ELS pilot (2022), HistoSonics Edison operational (2024). Existing coords 42.36N, 71.06W confirmed.","createdAt":"2026-08-08T20:16:29.044Z","updatedAt":"2026-08-12T22:20:10.919Z"},"operator":{"id":"02ead9de-6bce-472d-9e76-d9c954d8d603","name":"Microbot Medical","slug":"microbot-medical","description":"Microbot Medical Inc. (Nasdaq: MBOT) is a commercial-stage medical device company developing the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The company received FDA 510(k) clearance in September 2025 and commenced limited market release in November 2025, expanding to a full market release in Q2 2026. Headquartered in Hingham, Massachusetts with R&D operations in Yokneam, Israel.","status":"public","founded":2011,"hq":"Hingham, MA, USA","hqLat":42.2417669,"hqLng":-70.8897676,"hqGeocodedAt":"2026-08-05T00:51:16.415Z","hqAddress":null,"hqPrecision":null,"website":"microbotmedical.com","fundingTotal":"92200000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://ir.microbotmedical.com/news-events/press-release","title":"Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System","sourceName":"GlobeNewswire"}],"keyFacts":[{"label":"FDA cleared","value":"LIBERTY Endovascular Robotic System; Nasdaq=MBOT"},{"label":"Stock","value":"Nasdaq: MBOT"},{"label":"Product","value":"LIBERTY Endovascular Robotic System"},{"label":"FDA clearance","value":"510(k) (2025)"},{"label":"Key feature","value":"Single-use, remotely operated"},{"label":"Ticker","value":"MBOT (Nasdaq)"},{"label":"Category","value":"Endovascular surgical robotics"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"MBOT","stockExchange":"NASDAQ","secCik":"0000883975","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-02T21:26:26.164Z","updatedAt":"2026-08-21T22:25:39.297Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/liberty-endovascular-boston-massachusetts-usa","url":"https://registry.deploy.report/deployments/liberty-endovascular-boston-massachusetts-usa","name":"LIBERTY Endovascular Robotic System at Boston, Massachusetts, USA","identifier":"b3fa733e-8f42-4ddb-b08f-20514f1b4cd5","startDate":"2024-07-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/boston-massachusetts-usa","name":"Boston, Massachusetts, USA"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/microbot-medical","name":"Microbot Medical"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/liberty-endovascular","name":"LIBERTY Endovascular Robotic System"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}